Your browser doesn't support javascript.
loading
Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?
Marchetti, Michael A; Bartlett, Edmund K; Dusza, Stephen W; Bichakjian, Christopher K.
Affiliation
  • Marchetti MA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: marchetm@mskcc.org.
  • Bartlett EK; Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dusza SW; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Bichakjian CK; Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan.
J Am Acad Dermatol ; 80(6): e161-e162, 2019 06.
Article in En | MEDLINE | ID: mdl-30586612
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2019 Document type: Article Country of publication: United States